The GULP1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from HeLa cells, designed to disrupt GULP1 and create a loss-of-function model. This polyclonal knockout approach yields a heterogeneous cell pool, mitigating clonal artifacts and enabling robust investigation of GULP1-dependent processes in a human epithelial context. The cells provide a versatile platform for studying engulfment, phagocytosis, and downstream signaling without requiring clonal selection.
HeLa cells are an immortalized human cervical adenocarcinoma epithelial cell line widely employed in biomedical research. Their rapid proliferation, amenability to genetic modification, and extensively characterized signaling networks make them ideal for functional genomics. HeLa cells express endogenous engulfment machinery, allowing direct examination of GULP1??s role in apoptotic cell clearance and related pathways. This model is particularly relevant for cervical, ovarian, and breast cancer studies, as well as for investigations into neurodegeneration.
Mechanistically, GULP1 acts as an adaptor that links phagocytic receptors BAI1 and stabilin-2 to the ELMO/Dock180/Rac1 signaling axis. Upon receptor binding to phosphatidylserine-exposing apoptotic targets, GULP1 is recruited and interacts with ELMO, facilitating Dock180-mediated nucleotide exchange on Rac1. Active Rac1 drives actin polymerization, promoting membrane extension and internalization. GULP1 also engages integrin signaling and amyloid-beta uptake pathways, positioning it at a critical junction for cytoskeletal reorganization and cell motility.
In HeLa cells, GULP1 knockout enables dissection of how engulfment signaling intersects with epithelial cancer cell behavior. The polyclonal knockout population mirrors the genetic diversity found in tumors, enhancing its relevance for studying migration, invasion, and drug resistance. Since HeLa cells can internalize amyloid-beta oligomers, this knockout model is valuable for Alzheimer??s research, facilitating exploration of GULP1-dependent clearance mechanisms and their contribution to neurodegeneration.
These polyclonal GULP1 knockout HeLa cells support a range of experimental approaches. Phagocytosis assays using fluorescently labeled apoptotic cells or amyloid-beta aggregates can quantify engulfment defects. Western blotting and immunofluorescence allow detection of key signaling components such as BAI1, stabilin-2, ELMO, Dock180, Rac1, and actin. Flow cytometry enables high-throughput analysis of phagocytic activity, while migration and invasion assays assess metastatic potential. Apoptosis assays reveal crosstalk between cell death and engulfment pathways. For technical assistance and ordering, contact Ascent Research.
